GENOSKIN

Questions about NativeSkin access®? We've got answers! We are excited to unveil our brand-new FAQ page designed to address everything you need to know about NativeSkin access®. From culture conditions to regulatory considerations, we’ve covered it all in one convenient resource. 🔎 What you'll find: - Detailed insights into how NativeSkin access® works - Information on ethical sourcing and preparation of live human skin models - Answers to common research and logistical questions Whether you are in drug development, cosmetic testing, or academic research, this page is your go-to resource for making the most of NativeSkin access®. 👉 Explore the FAQ now: https://lnkd.in/eueuFA9s

New Data on T Cell Activation in Psoriasis Research! InflammaSkin® is setting a new benchmark for studying T cell-mediated inflammation in a psoriasis-like environment. Our latest data reveals: ✅ Elevated T Cell Activation: CD69 expression is higher in T cells from InflammaSkin® vs. HypoSkin® models. ✅ Proliferative Dynamics: Ki-67 highlights hyperproliferation typical of psoriasis in InflammaSkin® models. ✅ Immune Complexity: Double-positive CD4+CD8+ T cells were identified using flow cytometry and multiplex spatial analysis. These insights showcase InflammaSkin® as a powerful tool for understanding immune responses and evaluating T cell-targeted therapies. 📄 Download the full application note to explore the details and elevate your psoriasis research: https://bit.ly/3BcmPw3

Access Human Skin Like Never Before Discover the new NativeSkin access® webpage now! Whether you are working in pharma, biotech, cosmetics, or consumer goods, Genoskin’s ex vivo human skin models offer unparalleled insights with ethically sourced, live human skin tissue. 👀 What’s new on the page? ✅ Enhanced User Experience: Find all the information you need quickly and easily. ✅ Step-by-Step Guide on How to Order: Genoskin supports you all the way, from recommendations on the right model to your study to logistics and administrative concerns. ✅ Resource Hub: Access user manuals, protocols and video tutorials to maximize your research potential. 🔗 Explore the full potential of NativeSkin access® now, visit the updated webpage here: https://bit.ly/3ZzSuRr Let us know how NativeSkin access® could support your next breakthrough! 👇

Looking for a reliable model to study subcutaneous (s.c.) and intradermal (i.d.) injections? Look no further than HypoSkin®, the only human skin model that combines real human skin, structural stability, and functional immune cells. 💉 To test HypoSkin®’s suitability for injectable drug studies, we performed s.c. and i.d. infusions using clinical-grade syringes. Here's what we found: ✔️ Localized Injection Behavior - Subcutaneous Injection: The solution stayed localized within the adipose layer and gradually diffused into the dermis and epidermis without leakage. - Intradermal Injection: The solution remained within the dermal compartment with slight diffusion into the epidermis and subcutaneous space. ✔️ Advanced Validation Using 3D X-ray tomography, we confirmed precise containment of injected substances within the HypoSkin® model. Whether you're developing biologics, small molecules, or testing delivery systems, HypoSkin® offers unparalleled insights into distribution, diffusion, and safety—without the need for animal models. Curious about the unique features of HypoSkin®? Explore more validation and advance your research! https://lnkd.in/ecDHSxMP #ToxicityTesting #DrugDelivery

Discover NativeSkin® Tape Stripped Models– A New Level of Insight into Skin Barrier Function! 🌐 For researchers focused on transdermal delivery, skincare, and barrier repair, the NativeSkin® Tape Stripped model offers a unique tool. By removing layers of the skin’s outermost barrier, this model mimics a compromised skin barrier—ideal for testing how compounds interact with and penetrate altered skin surfaces. 💡 Why should you use NativeSkin® Tape Stripped models? - Realistic Modeling: Represents conditions like dry skin or compromised barriers, giving results relevant to real-life applications. - Enhanced Testing Potential: Optimized for analyzing penetration and efficacy of topical treatments, from drugs to cosmetic formulations. - Human-Relevant Data: Utilizing our ex vivo human skin technology ensures data that translates more closely to clinical outcomes. Whether you’re developing the next breakthrough in skincare or assessing the safety of transdermal drug delivery, NativeSkin® Tape Stripped models provide the insights needed to advance your research. 👉 Ready to elevate your studies? Order NativeSkin access® Tape Stripped on Genoskin’s e-shop. https://lnkd.in/eU3PzUri #SkinBarrierResearch #TransdermalTesting

🔬 Medical Device Innovation Meets Human-Centric Testing In a world where medical devices like wound dressings, adhesive patches, and wearable monitors directly interact with human skin, ensuring safety and efficacy isn't just an option—it's essential. Genoskin’s HypoSkin® platform provides a unique, human-centered solution. Our ex vivo human skin model is suitable to assess both the toxicity and efficacy of medical devices. With HypoSkin®, researchers gain unprecedented insights into skin responses, testing devices under conditions that closely mimic real-life applications. Key Benefits: ✅ Enhanced Safety: Accurately predicts skin reactions, minimizing patient risk. ✅ Efficacy Insights: Determines real-world performance before deployment. ✅ Regulatory Compliance: Generates real human data to meet regulatory standards. Contact us to learn more about how HypoSkin® can advance your device development journey. https://bit.ly/4fLkVkM

Why wait until clinical trials to identify potential injection site reactions? How can you predict reactogenicity before even starting clinical trials? Our toxicity service platform offers predictive insights using ex vivo human skin models, allowing you to assess local immune reactions and anticipate adverse effects before they become an issue. With the power of AUDACY bioinformatics, we not only measure cytokine and chemokine profiles but also infer biological pathways triggered by your compound. This comprehensive approach reduces risks and accelerates development timelines. 📝 Learn how our services can support your R&D efforts. 📄 https://lnkd.in/eyzWjXtz #PharmaceuticalDevelopment #CRO #Biotechnology #ToxicityTesting #DrugSafety #PredictiveModeling #PharmaR&D #LifeSciencesInnovation

🔬 Revolutionizing Vaccine Research with Real Human Skin Models 🔬 Curious about how we can study immune responses more effectively? Dive into our latest blog on VaxSkin®, a unique platform integrating an ex vivo human skin model, multiomics and bioinformatics-based analysis offering a deeper, more accurate look at vaccine response, without relying on animal models. With the rise of complex vaccine formulations, understanding human immune responses is essential. VaxSkin® enables high-resolution analysis of how vaccines behave in a biologically relevant human skin environment, providing valuable data on efficacy, safety, and more. 👩🔬👨🔬 If you're focused on vaccine development, see how VaxSkin® can help advance your research in ways not previously possible. 👉 Read the blog to learn more: https://bit.ly/3UPyKqd #VaccineResearch #Immunology #VaccineDevelopment

🚨 New Frontiers in Preclinical Testing! Scientific poster with Astra Zenaca🚨 How can we reliably predict inflammatory reactions in response to subcutaneously injected drugs before they reach clinical trials? The answer lies in the HypoSkin® model, an ethical, human-based alternative to traditional animal testing. 📌 HypoSkin® uses fully human skin models to evaluate local inflammatory responses, capturing: Normal subcutaneous tissue architecture. Inflammatory singnature upon injection. Key cytokine markers over time. Learn how this technology enhances the predictability of drug safety testing while supporting ethical science. 🌱 👉🏻https://bit.ly/3YAHn99

📣 Exciting news! Our CEO, Pascal Descargues, PhD recently joined the Health Care Beat podcast hosted by the Seyfarth Shaw LLP! 🎙️ Pascal shared insights into Genoskin’s journey in the biotechnology space and highlighted how business immigration plays a crucial role in our growth strategy. From pioneering innovations to advancing preclinical research and product development, Pascal had the chance to dive into the impactful work we’re doing at Genoskin. Catch the episode to learn more about how we’re making strides in the biotech field.